This inventor holds 1 USPTO granted patent. Top assignee: Evonik Roehm Gmbh. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Innovations by Marcus Knöll in Pharmaceutical Dosage Forms
Introduction
Marcus Knöll is an accomplished inventor based in Heidesheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on enhancing the solubility and effectiveness of low-soluble active substances.
Latest Patents
One of Marcus Knöll's notable patents is for a multiparticle pharmaceutical dosage form designed for low-soluble active substances. This invention relates to an oral multiparticle pharmaceutical dosage form that reduces stomach pH values. The dosage form consists of a receptacle containing multiple pellets, particles, granules, or agglomerates with a mean diameter ranging from 50 to 2500 micrometers. The internal matrix layer includes an active agent that is neither a peptide nor a protein, along with a lipophilic matrix and a polymer with mucoadhesive properties. The external film coating is made of a polymer or an anionic copolymer, optionally formulated with conventional pharmaceutical additives. This innovative approach aims to improve the water solubility of the active agent, which is crucial for its effectiveness.
Career Highlights
Marcus Knöll is currently associated with Evonik Röhm GmbH, where he continues to advance his research and development efforts in pharmaceuticals. His expertise in creating effective pharmaceutical formulations has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Marcus has collaborated with notable colleagues, including Rosario Lizio and Hans-Ulrich Petereit. These collaborations have contributed to the successful development of innovative pharmaceutical solutions.
Conclusion
Marcus Knöll's contributions to the field of pharmaceuticals, particularly through his innovative patent for a multiparticle pharmaceutical dosage form, highlight his commitment to improving drug delivery systems. His work continues to influence the industry and enhance patient care.